Focus: Medtronic is a global leader in medical devices spanning cardiovascular, neurology, diabetes, and surgical specialties with 695 active job openings. The company operates across multiple therapeutic areas with a diverse portfolio of implantable devices, ablation systems, and monitoring solutions.
Profile data last refreshed Yesterday · AI intelligence enriched 2mo ago
Hot — 1980 jobs added in 30d
Net +424 (1980 new, 1556 removed). Aggressive expansion phase.
Medtronic offers stable, large-scale employment with strong commercial and operational growth, but career upside depends on your tolerance for incremental innovation in a mature, regulated industry.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
A surgical mapping agent approaching loss of exclusivity with limited ongoing revenue contribution.
Help build intelligence for Medtronic
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Medtronic's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Post-LOE product with competitive generic erosion limiting future upside.
4 discontinued, 2 duplicate formulations not shown
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Source: state DOL filings, aggregated via Big Local News
No recent FDA warnings or mass layoffs on record; company appears operationally stable, though regulatory risk remains inherent to medical device sector.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo